Characterisation of the pharmacokinetics of ethinylestradiol and drospirenone in extended-cycle regimens: population pharmacokinetic analysis from a randomised Phase III study

OBJECTIVES: The primary objective of this analysis was to characterise the steady-state pharmacokinetics (PK) of ethinylestradiol (EE) and drospirenone (DRSP) in a randomised Phase III study that investigated the contraceptive efficacy and safety of three different regimens of EE 20 µg/DRSP 3 mg. ME...

Descripción completa

Detalles Bibliográficos
Autores principales: Reif, Stefanie, Snelder, Nelleke, Blode, Hartmut
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2013
Materias:
Electronic Pages
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3632974/
https://www.ncbi.nlm.nih.gov/pubmed/23493606
http://dx.doi.org/10.1136/jfprhc-2012-100397

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3632974/
https://www.ncbi.nlm.nih.gov/pubmed/23493606
http://dx.doi.org/10.1136/jfprhc-2012-100397

Ejemplares similares